Journal
EXPERT REVIEW OF ANTICANCER THERAPY
Volume 18, Issue 8, Pages 719-722Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14737140.2018.1483241
Keywords
Lung cancer; urothelial cancer; checkpoint inhibitor; combination immunotherapy; anti-PD-L1; immunotherapy
Categories
Funding
- NATIONAL CANCER INSTITUTE [ZIABC011896] Funding Source: NIH RePORTER